Suppr超能文献

澳大利亚和新西兰 Fontan 注册研究中 1428 例患者的再次干预和生存情况。

Reintervention and survival in 1428 patients in the Australian and New Zealand Fontan Registry.

机构信息

Cardiac Surgery, Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.

Heart Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

出版信息

Heart. 2020 May;106(10):751-757. doi: 10.1136/heartjnl-2019-315430. Epub 2019 Oct 29.

Abstract

OBJECTIVE

Patients undergoing single-ventricle palliation have experienced significant improvement in survival in the recent era. However, a substantial proportion of these patients undergo reoperations. We performed a review of the Australia and New Zealand (ANZ) Fontan Registry to determine the overall reintervention and reoperative burden in these patients.

METHODS

A retrospective longitudinal cohort study was performed using data from patients who underwent a Fontan operation between 1975 and 2016 from the ANZ Fontan Registry. The data obtained included Fontan operation, reinterventions and most recent follow-up status. We examined the type and timing of reinterventions and survival.

RESULTS

Of the 1428 patients identified, 435 (30%) underwent at least one reintervention after the Fontan operation: 110 patients underwent early reintervention and 413 underwent late reinterventions. Excluding Fontan conversion and transplantation, 220 patients underwent at least one interventional procedure and 209 patients underwent at least one reoperation. Fenestration closure and pacemaker-related procedures were the most common catheter and surgical interventions, respectively. The cumulative incidence of reintervention following Fontan was 23%, 37% and 55% at 10, 20 and 30 years, respectively. Survival and freedom from failure were worse in patients requiring later reintervention after Fontan surgery (51% vs 83% and 42% vs 69%, respectively at 30 years, p<0.001). This difference persisted after excluding pacemaker-related procedures (p<0.001). Operative mortality for non-pacemaker late reoperations after Fontan was 6%.

CONCLUSIONS

A substantial proportion of Fontan patients require further intervention to maintain effective single-ventricle circulation. Patients undergoing reoperation after Fontan have higher rates of mortality and failure, despite intervention.

摘要

目的

在近期,接受单心室姑息治疗的患者的生存率有了显著提高。然而,其中相当一部分患者需要再次手术。我们对澳大利亚和新西兰(ANZ)Fontan 注册中心进行了回顾性纵向队列研究,以确定这些患者的总体再干预和再次手术负担。

方法

使用澳大利亚和新西兰 Fontan 注册中心 1975 年至 2016 年间接受 Fontan 手术的患者数据进行回顾性纵向队列研究。获得的数据包括 Fontan 手术、再干预和最近的随访情况。我们检查了再干预的类型和时间以及生存率。

结果

在 1428 名患者中,有 435 名(30%)在 Fontan 手术后至少进行了一次再干预:110 名患者进行了早期再干预,413 名患者进行了晚期再干预。不包括 Fontan 转换和移植,220 名患者至少进行了一次介入治疗,209 名患者至少进行了一次手术。心房间隔缺损封堵术和起搏器相关手术分别是最常见的导管和外科干预措施。Fontan 术后再干预的累积发生率分别为 10、20 和 30 年时的 23%、37%和 55%。Fontan 手术后需要进行晚期再干预的患者的生存率和免于失败率较差(30 年时分别为 51%对 83%和 42%对 69%,p<0.001)。在排除起搏器相关手术后,这种差异仍然存在(p<0.001)。Fontan 后非起搏器晚期再次手术的手术死亡率为 6%。

结论

相当一部分 Fontan 患者需要进一步干预以维持有效的单心室循环。Fontan 后接受再手术的患者尽管进行了干预,但死亡率和失败率仍然较高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验